Malignant Pleural Mesothelioma - All About Malignant Mesothelioma Launches Updated Section On Mesothelioma Drug Treatments

All About Malignant Mesothelioma Launches Updated Section On Mesothelioma Drug Treatments
LA JOLLA, Calif.----July 14, 2006--All About Malignant Mesothelioma, an online resource for information about mesothelioma causes, symptoms and treatments, has recently published a revised section on mesothelioma drug treatments.

Lilly Reports Second-Quarter EPS of $.76
INDIANAPOLIS, July 21 /PRNewswire-FirstCall/ -- Eli Lilly and Company announced financial results for the second quarter of 2006. Second-Quarter Highlights * Sales increased 5 percent, to $3.867 billion.

Malignant Pleural Mesothelioma - Nippon Kayaku Seeking Additional Approval for Antitumor Agent

Nippon Kayaku Seeking Additional Approval for Antitumor Agent
JCN Newswire - The company expects to obtain additional approval for the combination therapy of Randa and pemetrexed, which is indicated for the treatment of malignant pleural mesothelioma. Currently in Japan, the number of people who die from malignant pleural

Eli Lilly Japan Seeking Additional Approval for Pemetrexed and
JCN Newswire - Pemetrexed and cisplatin are indicated for the treatment of malignant pleural mesothelioma. Initially approved in the US in 2004, the combination therapy - the only of its kind - is now available in over 70 countries worldwide. Malignant pleural